Špela Smrkolj

1.2k total citations
44 papers, 421 citations indexed

About

Špela Smrkolj is a scholar working on Molecular Biology, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Špela Smrkolj has authored 44 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Obstetrics and Gynecology and 12 papers in Epidemiology. Recurrent topics in Špela Smrkolj's work include Endometrial and Cervical Cancer Treatments (13 papers), Cervical Cancer and HPV Research (11 papers) and Ovarian cancer diagnosis and treatment (8 papers). Špela Smrkolj is often cited by papers focused on Endometrial and Cervical Cancer Treatments (13 papers), Cervical Cancer and HPV Research (11 papers) and Ovarian cancer diagnosis and treatment (8 papers). Špela Smrkolj collaborates with scholars based in Slovenia, Germany and Argentina. Špela Smrkolj's co-authors include Irma Virant‐Klun, Tea Lanišnik Rižner, Snježana Frković Grazio, Ivan Verdenik, Katja Vouk, S Rakar, Vladimir Smrkolj, Erik Škof, Jerzy Adamski and Cornelia Prehn and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Environmental Research and Public Health and Gynecologic Oncology.

In The Last Decade

Špela Smrkolj

42 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Špela Smrkolj Slovenia 12 173 123 109 107 82 44 421
Л. А. Коломиец Russia 13 196 1.1× 118 1.0× 78 0.7× 99 0.9× 82 1.0× 95 426
Malee Warnnissorn Thailand 10 135 0.8× 109 0.9× 37 0.3× 130 1.2× 65 0.8× 32 371
Judy Walls United States 9 170 1.0× 114 0.9× 58 0.5× 63 0.6× 34 0.4× 12 448
Lindsey E. Minion United States 8 142 0.8× 170 1.4× 90 0.8× 90 0.8× 34 0.4× 15 438
Uwe-Jochen Göhring Germany 13 163 0.9× 199 1.6× 70 0.6× 74 0.7× 24 0.3× 35 531
Congrong Liu China 11 86 0.5× 67 0.5× 79 0.7× 70 0.7× 32 0.4× 29 309
Adela Poitevin Mexico 8 94 0.5× 153 1.2× 136 1.2× 77 0.7× 79 1.0× 11 406
Lingfang Xia China 15 118 0.7× 172 1.4× 205 1.9× 64 0.6× 112 1.4× 35 485
Fanfei Kong China 15 422 2.4× 151 1.2× 62 0.6× 378 3.5× 40 0.5× 26 626
Antonia Wenners Germany 11 101 0.6× 102 0.8× 26 0.2× 74 0.7× 18 0.2× 21 306

Countries citing papers authored by Špela Smrkolj

Since Specialization
Citations

This map shows the geographic impact of Špela Smrkolj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Špela Smrkolj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Špela Smrkolj more than expected).

Fields of papers citing papers by Špela Smrkolj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Špela Smrkolj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Špela Smrkolj. The network helps show where Špela Smrkolj may publish in the future.

Co-authorship network of co-authors of Špela Smrkolj

This figure shows the co-authorship network connecting the top 25 collaborators of Špela Smrkolj. A scholar is included among the top collaborators of Špela Smrkolj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Špela Smrkolj. Špela Smrkolj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valenčak, Anja Oštrbenk, et al.. (2024). Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening. Journal of Clinical Virology. 170. 105638–105638. 9 indexed citations
2.
3.
Smrkolj, Špela, et al.. (2023). Decreased Gene Expression of Antiangiogenic Factors in Endometrial Cancer: qPCR Analysis and Machine Learning Modelling. Cancers. 15(14). 3661–3661. 1 indexed citations
4.
Luzar, Boštjan, et al.. (2023). Vulvar Lichen Planus Presenting as Chronic Vulvar Purpura. Medicina. 59(2). 206–206.
5.
Smrkolj, Špela, et al.. (2022). The Reliability and Medical Students’ Appreciation of Certainty-Based Marking. International Journal of Environmental Research and Public Health. 19(3). 1706–1706. 1 indexed citations
6.
Cvjetičanin, Branko, et al.. (2022). Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report. Medicina. 58(3). 339–339. 4 indexed citations
7.
Škof, Erik, et al.. (2022). Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment. Cancers. 14(3). 631–631. 34 indexed citations
8.
Smrkolj, Špela, et al.. (2022). Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer. Frontiers in Oncology. 12. 972131–972131. 6 indexed citations
9.
Ivanuš, Urška, Leon Meglič, Margareta Strojan Fležar, et al.. (2021). The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry. The Lancet Regional Health - Europe. 5. 100101–100101. 30 indexed citations
10.
Meznarič, Marija, et al.. (2019). Cancer stem cell-related marker NANOG expression in ovarian serous tumors using Western blotting and immunohistochemistry: comparison of two techniques. European Journal of Gynaecological Oncology. 40(6). 948–948. 1 indexed citations
11.
Vouk, Katja, et al.. (2018). Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer. The Journal of Steroid Biochemistry and Molecular Biology. 178. 312–321. 41 indexed citations
12.
Osredkar, Joško, Špela Smrkolj, Katja Vouk, et al.. (2017). Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer. Gynecologic Oncology. 147(1). 126–132. 34 indexed citations
13.
14.
15.
Verdenik, Ivan, et al.. (2017). STAR and AKR1B10 are down-regulated in high-grade endometrial cancer. The Journal of Steroid Biochemistry and Molecular Biology. 171. 43–53. 18 indexed citations
16.
Smrkolj, Špela, et al.. (2011). Advanced embryonal rhabdomyosarcoma of the uterine cervix: a case report.. PubMed. 32(2). 203–5. 4 indexed citations
17.
Rakar, S, et al.. (2008). Clinical audit of patients with cervical cancer in Slovenia. Data analysis from 2003-2006.. PubMed. 29(6). 628–32. 1 indexed citations
18.
Takač, Iztok, et al.. (2008). Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 140(1). 82–89. 10 indexed citations
19.
Rakar, S, et al.. (2005). Clinical audit of patients with cervical cancer in Slovenia--data analysis for the year 2003.. PubMed. 26(5). 537–42. 1 indexed citations
20.
Smrkolj, Špela, et al.. (2004). Evaluation of causes of increased incidence of cervical cancer in Slovenia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 117(2). 213–221. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Л. А. Коломиец Breakdown of academic impact, for papers by Malee Warnnissorn Breakdown of academic impact, for papers by Judy Walls Breakdown of academic impact, for papers by Lindsey E. Minion Breakdown of academic impact, for papers by Uwe-Jochen Göhring Breakdown of academic impact, for papers by Congrong Liu Breakdown of academic impact, for papers by Adela Poitevin Breakdown of academic impact, for papers by Lingfang Xia Breakdown of academic impact, for papers by Fanfei Kong Breakdown of academic impact, for papers by Antonia Wenners
Rankless by CCL
2026